• LifeTech Scientific dropped plans to acquire Starway Equity, ending talks on definitive documents for the deal.
• Negotiations with the seller failed to reach terms on the equity purchase agreement and the instrument for the Convertible Bonds.
• No shareholder circular will be issued, no EGM will be held, and the planned Convertible Bonds issue under a specific mandate will not proceed.
• The board expects no material impact on day-to-day operations, citing a shift in focus to product launches and overseas expansion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. LifeTech Scientific Corporation published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260720-12249921), on July 20, 2026, and is solely responsible for the information contained therein.